Navigating nitrosamine impurities: An in silico approach to risk assessment
In the ever-evolving landscape of pharmaceutical development, ensuring the safety and efficacy of medications is paramount. One of the emerging challenges in this field is the detection and management of nitrosamine impurities—potentially carcinogenic compounds that can form during drug manufacturing. To address this, having a robust workflow for nitrosamine impurity risk assessments is essential. In […]
Navigating nitrosamine impurities: An in silico approach to risk assessment Read More »
